Press Release: ViiMed contracts with Johns Hopkins HealthCare to bring digital health solutions for diabetes to hospitals, health systems, employers, and payors, and patients
WASHINGTON, D.C., December 14, 2017 – ViiMed, a Washington, D.C.-based digital health company, announces that it has signed a five-year contract with Johns Hopkins HealthCare LLC, a division of Johns Hopkins Medicine to convert their evidenced-based health solutions to digital form and offer them to hospitals and patients.
Digital health solutions on the ViiMed Platform share a common goal – improve patient outcomes by virtually engaging, managing, monitoring, and coordinating the patient and care team in and out of the health care setting. The focus of the two initial Johns Hopkins programs is on changing behavior of individuals with either pre-diabetes or type 2 diabetes.
The DECIDE program helps people with diabetes learn to change their behavior so they can better self-manage. This unique interactive program improves both self-management skills and diabetes health outcomes. Developed by Felicia Hill-Briggs, Ph.D., senior director of Population Health Research and Development at Johns Hopkins HealthCare, professor of medicine at the Johns Hopkins University School of Medicine, DECIDE has shown positive outcomes in studies of high risk, low-literacy populations. In addition, the program has been shown to improve A1C levels, blood pressure and cholesterol.
ACT2 is an interactive, year-long support and engagement program that is designed to empower those at high-risk of diabetes to take charge of their own health and well-being. Based on the Centers for Disease Control and Prevention’s National Diabetes Prevention Program curriculum, ACT2 will combine education, remote monitoring, and behavior change into one program for those diagnosed with pre-diabetes. In 2018, the Centers for Medicare & Medicaid Services is scheduled to announce performance-based reimbursement for diabetes prevention, and ACT2 will seamlessly enable organizations to implement this program into their workflow.
“We are grateful to Johns Hopkins HealthCare and the Solutions’ team – they believed in us; helped shape our platform and solidified our vision to power and commercialize digital health solutions,” said Phil Newman, ViiMed’s founder and chief product officer. “We believe the health care market gains access to very innovative solutions through our ecosystem, and we really see our strategy as the next chapter in digital health.”
When asked what to expect next, Rick Holbrook, ViiMed’s CEO, said, “We have several digital health solutions that address population health concerns in the works, and we are very focused on ramping up our commercialization efforts through direct sales and collaborations/integrations with complementary technology offerings.”
The DECIDE and ACT2 digital solutions from Johns Hopkins HealthCare are available exclusively on the ViiMed Platform for hospitals/health systems, physician groups, health plans, employers, payors, and governments, both in the United States and abroad.
ViiMed, a rapidly growing Washington D.C.-based healthcare technology company, provides a true platform that hospitals need to help coordinate care for all patients, improve workflows, reduce costs and risk for big parts of their business and help make care teams efficient and effective by touching more patients. They bring digital health solutions to life by taking leading healthcare organizations proven programs and practices for disease management and bundled procedure coordination to market on a single user-friendly platform. Hospitals, surgery centers, provider practices, employers and payors deploy these solutions when looking for meaningful and personalized ways to engage their patients, while empowering their care teams with tools to manage, monitor, and engage the right patients at the right time. ViiMed currently provides diabetes and orthopedic solutions and are in the process of developing several other disease and condition pathways.
Sorry, the comment form is closed at this time.